ஓட்டோலரிஞ்ஜாலஜி: திறந்த அணுகல்

சுருக்கம்

Dymista^© Nasal Spray with Multifocal Analysis of its Impact on the Rhinitis Disease Experience

Amtul Salam Sami *,Nida Ahmed

Background: Rhinitis is a prevalent condition both in primary care and in specialist centres. It has been shown to significantly impact on quality of life. Treatment is often best managed on combined therapies. Dymista© nasal spray is filling a niche for an ‘all in one’ treatment of allergic rhinitis. Method: The MSNOT-20 is a valid disease specific quality of life instrument for rhinitis and rhinosinusitis and it was used to evaluate the symptomatic response to treatment with Dymista nasal spray. Results: Dymista has been shown to improve all domains of the patient experience of rhinitis and rhinosinusitis with positive feedback by both patients and prescribing physicians. Conclusion: Dymista is effective at improving patient symptomatology and improves quality of life. These positive results have opened up further avenues for research to explore its efficiency and place as mode of treatment.